𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Changing Face of Colorectal Cancer in Inflammatory Bowel Disease: Progress at Last!

✍ Scribed by David T. Rubin

Book ID
119759198
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
70 KB
Volume
130
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Differential MicroRNA expression tracks
Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer
✍ Ziad Kanaan; Shesh N. Rai; M. Robert Eichenberger; Christopher Barnes; Amy M. Dw πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 486 KB πŸ‘ 1 views

## One of the most serious complications faced by patients with inflammatory bowel disease (IBD) is the potential development of colorectal cancer (CRC). There is a compelling need to enhance the accuracy of cancer screening of IBD patients. MicroRNAs (miRNAs) are small nonprotein-coding RNAs that

Chemoprophylaxis of colorectal cancer in
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts
✍ Jonathan S. Levine; Robert Burakoff πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review exa